共 6 条
[3]
新辅助化疗FEC方案和TEC方案对乳腺癌患者的疗效[J]. 王蓓,傅健飞,洪中武.癌症. 2009(03)
[5]
Comparison of 6 cycles versus 4 cycles of neoadjuvant epirubicin plus docetaxel chemotherapy in stages II and III breast cancer
[J].
EJSO,
2009, 35 (06)
:583-587
[6]
HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma. Learn PA,Yeh IT,McNutt M, et al. Cancer . 2005